NMR spectroscopic characterization of death domain superfamily proteins: Structures, dynamics and interactions

Nuclear Magnetic Resonance (NMR): Theory, Applications and Technology

Volumn , Issue , 2014, Pages 83-110

  Wei, Yufeng ^a   Twomey, Edward C ^b  

^a SETON HALL UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYST ACTIVITY; CELL DEATH; CHEMICAL ACTIVATION; CRYSTALLOGRAPHY; DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

BIOLOGICAL FUNCTIONS; BIOLOGICAL PATHWAYS; DOMAIN-DOMAIN INTERACTIONS; PROGRAMMED CELL DEATHS; PROTEIN-PROTEIN INTERACTIONS; SPECTROSCOPIC CHARACTERIZATION; STRUCTURAL DOMAINS; TUMOR NECROSIS FACTORS;

PROTEINS;

EID: 84938505214     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (101)

1. Park, H. H., et al., The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation. Annual Review of Immunology, 2007. 25(1): p. 561-586.
2. Kwon, D., et al., A comprehensive manually curated protein-protein interaction database for the Death Domain superfamily. Nucleic Acids Res., 2012. 40(Database issue): p. D331-6.
3. Reed, J. C., K. S. Doctor, and A. Godzik, The domains of apoptosis: a genomics perspective. Sci. STKE, 2004. 2004(239): p. re9.
4. McEntyre, J. R. and T. J. Gibson, Patterns and clusters within the PSM column in TiBS, 1992-2004. Trends Biochem. Sci., 2004. 29(12): p. 627-33.
5. Hu, S., et al., A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem., 1997. 272(15): p. 9621-4.
6. Bertin, J., et al., Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. U S A, 1997. 94(4): p. 1172-6.
7. Thome, M., et al., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature, 1997. 386(6624): p. 517-21.
8. Johnston, J. B., et al., A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity, 2005. 23(6): p. 587-98.
9. Czerski, L. and G. Nunez, Apoptosome formation and caspase activation: is it different in the heart? J. Mol. Cell Cardiol., 2004. 37(3): p. 643-52.
10. Zimmermann, K. C., C. Bonzon, and D. R. Green, The machinery of programmed cell death. Pharmacol. Ther., 2001. 92(1): p. 57-70.
11. Pirnia, F., et al., Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ., 2002. 9(9): p. 905-14.
12. Sutheesophon, K., et al., Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). J. Cell Physiol., 2005. 203(2): p. 387-97.
13. Swanton, E., et al., Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene, 1999. 18(10): p. 1781-7.
14. Thome, M. and J. Tschopp, Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol., 2001. 1(1): p. 50-8.
15. Zou, H., et al., Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 1997. 90(3): p. 405-13.
16. Li, P., et al., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997. 91(4): p. 479-89.
17. Adams, J. M. and S. Cory, Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol., 2002. 14(6): p. 715-20.
18. Lassus, P., X. Opitz-Araya, and Y. Lazebnik, Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science, 2002. 297(5585): p. 1352-4.
19. Duan, H. and V. M. Dixit, RAIDD is a new 'death' adaptor molecule. Nature, 1997. 385(6611): p. 86-9.
20. Tinel, A. and J. Tschopp, The PIDDosome, a Protein Complex Implicated in Activation of Caspase-2 in Response to Genotoxic Stress. Science, 2004. 304(5672): p. 843-846.
21. Berube, C., et al., Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc. Natl. Acad. Sci. U S A, 2005. 102(40): p. 14314-20.
22. Janssens, S., et al., PIDD mediates NF-kappaB activation in response to DNA damage. Cell, 2005. 123(6): p. 1079-92.
23. Cuenin, S., et al., p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene, 2008. 27(3): p. 387-96.
24. Kohl, A. and M. G. Grutter, Fire and death: the pyrin domain joins the death-domain superfamily. C. R. Biol., 2004. 327(12): p. 1077-86.
25. Tschopp, J., F. Martinon, and K. Burns, NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol., 2003. 4(2): p. 95-104.
26. Benko, S., D. J. Philpott, and S. E. Girardin, The microbial and danger signals that activate Nod-like receptors. Cytokine, 2008. 43(3): p. 368-73.
27. Martinon, F., K. Burns, and J. Tschopp, The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell, 2002. 10(2): p. 417-26.
28. Franchi, L., et al., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol., 2009. 10(3): p. 241-7.
29. Schroder, K. and J. Tschopp, The inflammasomes. Cell, 2010. 140(6): p. 821-32.
30. Huang, B., et al., NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature, 1996. 384(6610): p. 638-41.
31. Eberstadt, M., et al., NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature, 1998. 392(6679): p. 941-5.
32. Chou, J. J., et al., Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell, 1998. 94(2): p. 171-80.
33. Hiller, S., et al., NMR structure of the apoptosis-and inflammationrelated NALP1 pyrin domain. Structure, 2003. 11(10): p. 1199-205.
34. Wajant, H., The Fas signaling pathway: more than a paradigm. Science, 2002. 296(5573): p. 1635-6.
35. Jeong, E. J., et al., The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J. Biol. Chem., 1999. 274(23): p. 16337-42.
36. Berglund, H., et al., The three-dimensional solution structure and dynamic properties of the human FADD death domain. J. Mol. Biol., 2000. 302(1): p. 171-88.
37. Xiao, T., et al., Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell, 1999. 99(5): p. 545-55.
38. Park, H. H., et al., Death Domain Assembly Mechanism Revealed by Crystal Structure of the Oligomeric PIDDosome Core Complex. Cell, 2007. 128(3): p. 533-546.
39. Scott, F. L., et al., The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature, 2009. 457(7232): p. 1019-1022.
40. Wang, L., et al., The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol., 2010. 17(11): p. 1324-1329.
41. Yang, J. K., et al., Crystal Structure of MC159 Reveals Molecular Mechanism of DISC Assembly and FLIP Inhibition. Molecular Cell, 2005. 20(6): p. 939-949.
42. Li, F.-Y., et al., Crystal Structure of a Viral FLIP. Journal of Biological Chemistry, 2006. 281(5): p. 2960-2968.
43. Hill, J. M., et al., Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J., 2002. 21(23): p. 6494-6504.
44. Twomey, E. C. and Y. Wei, High-definition NMR structure of PED/PEA-15 death effector domain reveals details of key polar side chain interactions. Biochemical and Biophysical Research Communications, 2012. 424(1): p. 141-146.
45. Carrington, P. E., et al., The Structure of FADD and Its Mode of Interaction with Procaspase-8. Molecular Cell, 2006. 22(5): p. 599-610.
46. Braddock, D. T., et al., Rapid Identification of Medium-to Large-Scale Interdomain Motion in Modular Proteins Using Dipolar Couplings. Journal of the American Chemical Society, 2001. 123(35): p. 8634-8635.
47. Bang, S., et al., Fas-and Tumor Necrosis Factor-mediated Apoptosis Uses the Same Binding Surface of FADD to Trigger Signal Transduction: A Typical Model For Convergent Signal Transduction. Journal of Biological Chemistry, 2000. 275(46): p. 36217-36222.
48. Hill, J. M., et al., Identification of an expanded binding surface on the FADD death domain responsible for interaction with CD95/Fas. Journal of Biological Chemistry, 2004. 279(2): p. 1474-1481.
49. Muppidi, J. R., et al., Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death Differ., 2006. 13(10): p. 1641-50.
50. Sandu, C., et al., FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ., 2006. 13(12): p. 2052-61.
51. Twomey, E. C., D. F. Cordasco, and Y. Wei, Profound conformational changes of PED/PEA-15 in ERK2 complex revealed by NMR backbone dynamics. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2012. 1824(12): p. 1382-1393.
52. Vaughn, D. E., et al., Crystal structure of apaf-1 caspase recruitment domain: an a-helical greek key fold for apoptotic signaling. Journal of Molecular Biology, 1999. 293(3): p. 439-447.
53. Qin, H., et al., Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature, 1999. 399(6736): p. 549-57.
54. Zhou, P., et al., Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. Proc. Natl. Acad. Sci. U S A, 1999. 96(20): p. 11265-70.
55. Day, C. L., et al., Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1. Cell Death Differ., 1999. 6(11): p. 1125-32.
56. Riedl, S. J., et al., Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature, 2005. 434(7035): p. 926-933.
57. Inohara, N., et al., Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem., 1999. 274(21): p. 14560-7.
58. Inohara, N., et al., RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem., 1998. 273(20): p. 12296-300.
59. Inohara, N., et al., An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem., 2000. 275(36): p. 27823-31.
60. Thome, M., et al., Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol., 1998. 8(15): p. 885-8.
61. Manon, F., et al., Solution Structure of NOD1 CARD and Mutational Analysis of its Interaction with the CARD of Downstream Kinase RICK. Journal of Molecular Biology, 2007. 365(1): p. 160-174.
62. Coussens, N. P., et al., Crystal structure of the Nod1 caspase activation and recruitment domain. Biochemical and Biophysical Research Communications, 2007. 353(1): p. 1-5.
63. Srimathi, T., et al., Monomer/Dimer Transition of the Caspase-Recruitment Domain of Human Nod1,. Biochemistry, 2008. 47(5): p. 1319-1325.
64. Humke, E. W., et al., ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell, 2000. 103(1): p. 99-111.
65. Jin, T., et al., Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1. Proteins: Structure, Function, and Bioinformatics, 2013. 81(7): p. 1266-1270.
66. Le, H. T. and J. A. Harton, Pyrin-and CARD-only Proteins as Regulators of NLR Functions. Front Immunol., 2013. 4: p. 275.
67. Bae, J. Y. and H. H. Park, Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly. Journal of Biological Chemistry, 2011. 286(45): p. 39528-39536.
68. Pinheiro, A. S., et al., The NLRP12 Pyrin Domain: Structure, Dynamics, and Functional Insights. Journal of Molecular Biology, 2011. 413(4): p. 790-803.
69. Eibl, C., et al., Structural and Functional Analysis of the NLRP4 Pyrin Domain. Biochemistry, 2012. 51(37): p. 7330-7341.
70. Su, M.-Y., et al., Three-Dimensional Structure of Human NLRP10/PYNOD Pyrin Domain Reveals a Homotypic Interaction Site Distinct from Its Mouse Homologue. PLoS ONE, 2013. 8(7): p. e67843.
71. Liepinsh, E., et al., The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. J. Mol. Biol., 2003. 332(5): p. 1155-63.
72. Natarajan, A., R. Ghose, and J. M. Hill, Structure and Dynamics of ASC2, a Pyrin Domain-only Protein That Regulates Inflammatory Signaling. Journal of Biological Chemistry, 2006. 281(42): p. 31863-31875.
73. de Alba, E., Structure and Interdomain Dynamics of Apoptosisassociated Speck-like Protein Containing a CARD (ASC). Journal of Biological Chemistry, 2009. 284(47): p. 32932-32941.
74. Ayala, I., et al., An efficient protocol for the complete incorporation of methyl-protonated alanine in perdeuterated protein. Journal of Biomolecular NMR, 2009. 43(2): p. 111-119.
75. Park, H., PYRIN domains and their interactions in the apoptosis and inflammation signaling pathway. Apoptosis, 2012. 17(12): p. 1247-1257.
76. Valmiki, M. and J. Ramos, Death Effector Domain-Containing Proteins. Cellular and Molecular Life Sciences, 2009. 66(5): p. 814-830.
77. Fiory, F., et al., Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. American Journal of Physiology-Endocrinology And Metabolism, 2009. 297(3): p. E592-E601.
78. Danziger, N., et al., Cellular Expression, Developmental Regulation, and Phylogenic Conservation of PEA-15, the Astrocytic Major Phosphoprotein and Protein Kinase C Substrate. Journal of Neurochemistry, 1995. 64(3): p. 1016-1025.
79. Estellés, A., et al., The Major Astrocytic Phosphoprotein PEA-15 Is Encoded by Two mRNAs Conserved on Their Full Length in Mouse and Human. Journal of Biological Chemistry, 1996. 271(25): p. 14800-14806.
80. Renganathan, H., et al., Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J., 2005. 390(3): p. 729-735.
81. Krueger, J., et al., Phosphorylation of Phosphoprotein Enriched in Astrocytes (PEA-15) Regulates Extracellular Signal-regulated Kinasedependent Transcription and Cell Proliferation. Mol. Biol. Cell, 2005. 16(8): p. 3552-3561.
82. Araujo, H., et al., Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. Journal of Biological Chemistry, 1993. 268(8): p. 5911-5920.
83. Kubes, M., et al., Endothelin Induces a Calcium-Dependent Phosphorylation of PEA-15 in Intact Astrocytes: Identification of Ser104 and Ser116 Phosphorylated, Respectively, by Protein Kinase C and Calcium/Calmodulin Kinase II In Vitro. Journal of Neurochemistry, 1998. 71(3): p. 1307-1314.
84. Trencia, A., et al., Protein Kinase B/Akt Binds and Phosphorylates PED/PEA-15, Stabilizing Its Antiapoptotic Action. Mol. Cell. Biol., 2003. 23(13): p. 4511-4521.
85. Kitsberg, D., et al., Knock-Out of the Neural Death Effector Domain Protein PEA-15 Demonstrates That Its Expression Protects Astrocytes from TNFa-Induced Apoptosis. The Journal of Neuroscience, 1999. 19(19): p. 8244-8251.
86. Xiao, C., et al., Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells. Journal of Biological Chemistry, 2002. 277(28): p. 25020-25025.
87. Condorelli, G., et al., PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene, 1999. 18(31): p. 4409-15.
88. Formstecher, E., et al., PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase. Developmental Cell, 2001. 1(2): p. 239-250.
89. Callaway, K., et al., The Anti-Apoptotic Protein PEA-15 Is a Tight Binding Inhibitor of ERK1 and ERK2, Which Blocks Docking Interactions at the D-Recruitment Site. Biochemistry, 2007. 46(32): p. 9187-9198.
90. Condorelli, G., et al., PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J., 1998. 17(14): p. 3858-66.
91. Zhang, Y., et al., Regulation of Expression of Phospholipase D1 and D2 by PEA-15, a Novel Protein That Interacts with Them. Journal of Biological Chemistry, 2000. 275(45): p. 35224-35232.
92. Condorelli, G., et al., Protein Kinase C (PKC)-a Activation Inhibits PKC-d and Mediates the Action of PED/PEA-15 on Glucose Transport in the L6 Skeletal Muscle Cells. Diabetes, 2001. 50(6): p. 1244-1252.
93. Vigliotta, G., et al., Overexpression of the ped/pea-15 Gene Causes Diabetes by Impairing Glucose-Stimulated Insulin Secretion in Addition to Insulin Action. Mol. Cell. Biol., 2004. 24(11): p. 5005-5015.
94. Farina, B., et al., NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites. FEBS Journal, 2010. 277(20): p. 4229-4240.
95. Callaway, K., M. A. Rainey, and K. N. Dalby, Quantifying ERK2-protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2005. 1754(1-2): p. 316-323.
96. Kaoud, T. S., et al., Activated ERK2 Is a Monomer in Vitro with or without Divalent Cations and When Complexed to the Cytoplasmic Scaffold PEA-15. Biochemistry, 2011. 50(21): p. 4568-4578.
97. Twomey, E. C., et al., Substantial Conformational Change Mediated by Charge-Triad Residues of the Death Effector Domain in Protein-Protein Interactions. PLoS ONE, 2013. 8(12): p. e83421.
98. Mace, P. D., et al., Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat. Commun., 2013. 4: p. 1681.
99. Doti, N., et al., Residues 762-801 of PLD1 mediate the interaction with PED/PEA15. Molecular Biosystems, 2010. 6(10): p. 2039-2048.
100. Viparelli, F., et al., Targeting of PED/PEA-15 Molecular Interaction with Phospholipase D1 Enhances Insulin Sensitivity in Skeletal Muscle Cells. Journal of Biological Chemistry, 2008. 283(31): p. 21769-21778.
101. Farina, B., et al., Molecular basis of the PED/PEA15 interaction with the C-terminal fragment of phospholipase D1 revealed by NMR spectroscopy. Biochim. Biophys. Acta, 2013. 1834(8): p. 1572-80.